Eurobiomed: The Business Analysis Of Michael Porter's Diamond Model

Now, it is an important part of the cluster’s analysis to assess its competitiveness through the analysis of the diamond model, suggested and promoted by Michael Porter. The particular advantage of the usage of this particular model is that it enables researchers to look simultaneously at the cluster’s corporate strategy and the advantages of the location the cluster operates in (or a bunch of locations). Hence, it helps to look at all the types of vital strengths firm or cluster can take advantage of. Not only positive sides, but weaknesses should be identified, too, mainly in terms of key competitiveness issues which the cluster has to face - either from other clusters or other industries.

Porter’s diamond of national advantage consists of the four main pillars accompanied by the policies government and pure chance. Those are factor conditions or inputs, related and supporting industries, specificity of
In different statements promoting itself (REF) Eurobiomed highlights its beneficial location, open both to Europe and to the Northern coast of Africa; Mediterranean-African region, in its turn, is considered to be a market yet to be developed. What is more, the South of France is historically connected with clinical research which made it be one of the leading centers in Europe in infectiology, immunology, oncology, neurosciences, and ophthalmology, which are certainly to be seen as supporting industries for the cluster’s development (LINK).

Eurobiomed has developed a strong network of international connections. Cluster’s two main targets in this field are the United States and Japan. In particular, LINK-J, the cluster of Tokyo, and BIOCOM, the cluster of California, can be used as examples of Eurobiomed’s international cooperation. Not only the common projects in R&D but also the spirit of competitiveness vital for the industry’s growth and prosperity is being developed this